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Abstract
Background: For solid tumors, image cytometry has been shown to be more sensitive for
diagnosing DNA content abnormalities (aneuploidy) than flow cytometry. Image cytometry has
often been performed using the semi-automated CAS 200 system. Recently, an Automated Cellular
Imaging System (ACIS) was introduced to determine DNA content (DNA index), but it has not
been validated.
Methods: Using the CAS 200 system and ACIS, we compared the DNA index (DI) obtained from
the same archived formalin-fixed and paraffin embedded tissue samples from Barrett's esophagus
related lesions, including samples with specialized intestinal metaplasia without dysplasia, low-grade
dysplasia, high-grade dysplasia and adenocarcinoma.
Results: Although there was a very good correlation between the DI values determined by ACIS
and CAS 200, the former was 25% more sensitive in detecting aneuploidy. ACIS yielded a mean DI
value 18% higher than that obtained by CAS 200 (p < 0.001; paired t test). In addition, the average
time required to perform a DNA ploidy analysis was shorter with the ACIS (30–40 min) than with
the CAS 200 (40–70 min). Results obtained by ACIS gave excellent inter-and intra-observer
variability (coefficient of correlation >0.9 for both, p < 0.0001).
Conclusion: Compared with the CAS 200, the ACIS is a more sensitive and less time consuming
technique for determining DNA ploidy. Results obtained by ACIS are also highly reproducible.
Background
By molecular pathology, Barrett's adenocarcinoma has
been shown to be an acquired malignancy with multi-
genetic alterations involving almost all chromosomes
[1,2]. These observations have indicated that numerical
and structural chromosomal abnormalities may be
important events in the carcinogenic process in Barrett's
adenocarcinoma. This is especially important inasmuch
as there is accumulating evidence that DNA aneuploidy is
a key early event in tumorigenesis and may be a cause
rather than a consequence of malignancy [3,4]. Chromo-
somal abnormalities occur predominantly in aneuploid
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malignant cells, leading to progressive deterioration of
aneuploidy [5]. In addition to changes in chromosome
copy numbers, cancer cells may also experience a change
in the size of individual chromosomes, due to chromo-
somal translocations, deletions, and duplications. In flow
or image cytometry of cancer cells, DNA content is repre-
sented by the DNA index (DI) and described in reference
to the DI of normal diploid cells. DI values reflect inte-
grated optical density (IOD), which takes into account
chromosome copy number, extra chromosomal frag-
ments and the DNA content of individual chromosomes,
as well as morphometric features of the nuclei. Thus, DI
values reflect more than the copy number of the chromo-
somes in a nucleus, and the term aneuploidy, which was
originally introduced to indicate only changes in chromo-
some copy number, is now used to indicate any changes
in the DI of cancer and pre-cancerous cells.
DNA aneuploidy has been used as a marker of cancers that
exhibit more aggressive behavior than diploid cancers,
and as a marker of pre-malignant lesions that are at high
risk for malignant progression to cancer. Although DNA
aneuploidy has usually been measured by flow cytometry,
the sensitivity of this method is limited in diagnosing
DNA content abnormalities because it includes both
affected cells as well as benign epithelial and stromal cells
in the test sample. Image cytometry has recently been used
to estimate the DI of cells in disaggregated cytospin prep-
arations or in microscopically identified epithelial cells
[4]. Image cytometry has been shown to be more sensitive
than flow cytometry for analyzing DNA content [6,7].
Image cytometry has been performed using a number of
systems, the most common being the semi-automated
CAS 200 system [8-10]. Recently, a more automated sys-
tem, the Automated Cellular Imaging System (ACIS)
(ChromaVision Medical System, Inc., San Juan Capist-
rano, CA) was introduced for the analysis of DNA ploidy,
but results using this system have not been validated
against the conventional CAS 200 system. Using these two
systems, in the present work we compared the DNA index
(DI) obtained from the same archived formalin-fixed and
paraffin embedded tissue samples from Barrett's esopha-
gus related lesions, including those with dysplasia and
adenocarcinoma. We found that the two systems gave cor-
related DI values and that the ACIS system gave higher DI
values, diagnosed aneuploidy more frequently, and may
be less labor intensive than the CAS 200 system. Further-
more, results obtained with ACIS were highly
reproducible.
Methods
Tissue samples
A total of 34 distal esophageal biopsies or distal esopha-
geal resection specimens containing Barrett's esophagus
related lesions were collected from 13 patients. The DI of
these tissue samples had been examined using the CAS
200 (Becton Dickenson, San Jose, CA) [8] and were sub-
sequently assayed using the ACIS instrument. The study
protocol was approved by the Institutional Review Boards
of the Boston and Providence Veterans Affairs Medical
Centers.
Histology
The tissue blocks were sectioned to obtain two adjacent
sections, one stained with H&E and the other with Feul-
gen dye. The H&E stained sections were examined by two
experienced pathologists (Q.H. and M.K.) for consensus
diagnoses of Barrett's esophagus with specialized intesti-
nal metaplasia (SIM), without dysplasia (BE), and for
low-grade dysplasia (LGD), high-grade dysplasia (HGD),
and esophageal adenocarcinoma (EAC), according to
published criteria [11,12]. Briefly, SIM was diagnosed if
the esophageal epithelium was columnar and contained
characteristic goblet cells [11]. A diagnosis of LGD
depended primarily on prominent cytological changes
such as enlarged nuclei with hyperchromasia and
increased number of mitoses as well as mild architectural
changes. The crypt architecture in LGD was slightly dis-
torted but generally preserved. The epithelial nuclei were
enlarged, crowded, and hyperchromatic with increased
mitotic figures, and the changes were present in the upper
portion of the crypt. The nuclei remained polarized but
were slightly stratified, and the stratification did not reach
the apical surface of the glands. Mucus in the goblet and
columnar cells was diminished or absent. In contrast,
samples with high-grade dysplasia (HGD) showed
marked cytological and architectural changes, including
abnormal glandular proliferations with villiform and cri-
briform growth patterns in the upper portion of the
mucosa, and marked distortion of crypt architecture with
branching, lateral budding of crypts, and "back-to-back"
patterns [12]. Nuclear stratification reached the crypt
luminal surface, with loss of nuclear polarity, and nuclei
varied markedly in size, shape and staining characteristics.
The nuclear abnormalities extended to the mucosal sur-
face. Mucin production in the goblet and columnar cells
was usually absent. Esophageal adenocarcinoma (EAC)
was diagnosed when dysplastic columnar epithelial cells
invaded through the basement membrane into the mus-
cularis mucosa, submucosa, and beyond.
DNA index (DI) determination by CAS 2000
For analysis on the CAS 200 System, fixed 5 µm tissue sec-
tions were Feulgen-stained using the Quantitative DNA
Staining Kit (Cell Analysis Systems, Inc., Elmhurst, IL) as
recommended by the manufacturer. This staining process
involves hydrolysis with concentrated hydrochloric acid,
that removes non-nuclear substances and hydrolyses
chromatin into its constituent nucleic acids, followed by
stoichiometric binding of the dye to the nucleic acids,BMC Clinical Pathology 2005, 5:7 http://www.biomedcentral.com/1472-6890/5/7
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imparting a blue color. The intensity of the blue color is
directly proportional to the amount of DNA. Areas on the
Feulgen-stained sections that contained pathological
lesions, as defined by adjacent H&E stained slides, were
marked for DNA content analysis. The corresponding
areas on the Feulgen-stained sections were scanned, digi-
tized, and stored as individual files using the CAS 200
quantitative DNA software program [13]. Artifacts,
including overlapping nuclei, were edited out. The digi-
tized images of microscopically selected nuclei were con-
verted into a series of pixels, which were quantified on the
basis of parameters such as the integrated optical density
(IOD), reflecting the DNA content of the selected nucleus.
CAS 200 also uses a tissue correction software, which cor-
rects for underestimation of DI due to cutting off of the
nuclei. Both the Feulgen staining and ploidy analysis on
the CAS 200 were performed in the Molecular Pathology
Laboratory of Columbia University Medical Center in
New York City, according to standard protocols and insti-
tutional criteria [8,13].
DNA index determination by ACIS
DNA content analysis on ACIS was performed according
to the procedures suggested by the manufacturer. Briefly,
the sections were cut at 7 µm and stained with Feulgen
stain (ACIS kit), which includes hydrolysis with hydro-
chloric acid that removes non-nuclear substances and
purines from the deoxyribose backbone of DNA mole-
cules, followed by reaction with Schiff's reagent, an aque-
ous solution of cresyl-violet and sulfurous acid. Thus, the
amount of Feulgen stain is directly proportional to the
amount of DNA present in the nucleus. Feulgen-stained
slides were automatically scanned with an Olympus
microscope equipped with 3 Sony digital CCD chips at a
speed of 30-frames/second. At a 40× magnification, the
final estimated resolution was 250,000 per pixel (770,000
per airy disk), each individual Field of View (FOV) meas-
ured 160 × 120 µm, and there were157 × 209 (32,813)
FOVs on a slide. Only the properly and uniformly stained
slides were included. The final display was a 24-bit resolu-
tion (1280 × 1024), with the area of interest captured at
40× magnification. A daily quality control run with a
standard calibration kit from the manufacturer was per-
formed to ensure proper focus, black and white level bal-
ance for each microscope objective, and linear camera
output.
The ACIS uses an inbuilt system that sets the filter thresh-
old controlling the inclusion of stained nuclei at prede-
fined (1–5) levels. The operator selects the level that helps
the user separate/cut in between adjacent cells and cannot
be identified by the software as individual cells, ranging
from the least (level 1) to the most (level 5) aggressive.
The system 'remembers' analysis regions to prevent the
user from re-collecting nuclei from the same region.
Unlike the CAS 200, no tissue correction factor is applied
in the ACIS system to correct for underestimation of DI.
To avoid inclusion of touching and overlapping nuclei,
ACIS uses a set of image processing algorithms known as
Watershed Segmentation. In these algorithms, nuclei that
touch or overlap other nuclei are recognized through their
size and other morphometric parameters and are sepa-
rated by insertion of a single pixel-wide boundary at the
point of contact. The analysis software provides five dis-
tinct cell separation profiles to allow optimal separation
across a range of specimen morphologies, a process that
works well for nuclei that touch or overlap to a modest
degree. To avoid inclusion of excessively overlapped
nuclei, each of the cell separation profiles was designed to
recognize and exclude nuclei that exhibit excessive over-
lapping based on signature combinations of size, shape,
color and morphometric filter descriptors.
Overlapping nuclei, nuclear debris and other artifacts that
escaped auto-detection and removal by the system were
deleted by the operator. Qualified nuclei of approxi-
mately 30 control stromal cells, such as endothelial cells,
macrophages, and fibroblasts, in the same tissue and
about 200-targeted epithelial cells are obtained. DNA
content histograms are automatically plotted in another
window using the ACIS DNA ploidy software (Figure 1).
The user can easily navigate between individual nuclei
and their exact position on the DI histogram.
The mean integrated optical density (IOD) of control cells
is assigned a DI of 1, which serves as an internal diploid
(2N) standard and reference for DI calculation of the tar-
geted cells. The IOD of control cells has a coefficient of
variation (CV) of less than 10%. The histograms of the tar-
get cells showed a primary G0/G1 peak, and additional
cells with or without well defined peaks with DI outside
the G0/G1 peak (e.g., in S- or G2 phase of the cell cycle).
Reproducibility of the ACIS
We randomly selected 30 samples of Barrett's lesions,
including 5 cases each of gastric cardiac mucosa, SIM, ID
(Indefinite for Dysplasia), LGD, HGD and EAC. To deter-
mine inter-observer variability, two trained, independent
observers who were blinded to the diagnosis separately
performed DI analysis on the same slide. To determine
intra-observer reproducibility, the same observer per-
formed DI analyses on the same slide at an interval of
more than 15 days.
Aneuploidy determination
Aneuploidy was diagnosed when the targeted epithelial
nuclei showed no diploid G0/G1 peak and the DI of the
G0/G1 peak was clearly positioned outside the diploid
range.BMC Clinical Pathology 2005, 5:7 http://www.biomedcentral.com/1472-6890/5/7
Page 4 of 10
(page number not for citation purposes)
Statistical analysis
Statistical analysis was performed largely with Microsoft
Excel. For linear regression analysis, the software SPSS
(Chicago) was used. A p value of < 0.05 was considered
statistically significant.
Results
DI values determined by the CAS 200 and ACIS systems
Figure 2 shows examples of DI histograms obtained with
the CAS 200 and ACIS instruments on distal esophageal
tissue samples with various pathologic lesions. In general,
we found that the ACIS yielded G0/G1 peaks with higher
DI values than the CAS 200 system. When we assessed
individual DI values of G0/G1 peaks obtained with the
two systems, we again found that, in most cases and in all
histopathological types of Barrett related lesions, the ACIS
yielded higher DI values (p < 0.001, paired t test; Figure 3).
On average, the DI values obtained with the ACIS were
18% higher than those obtained with the CAS 200. Both
linear and logistical correlation analyses showed a statisti-
cally significant correlation between DI values generated
by the two instruments (p < 0.01, two tailed; Figure 4).
Ploidy analysis
Diagnoses of aneuploidy have been based on the upper
limit of normal G0/G1 peak DI values, which vary from
1.1 to 1.29. Using 1.1 as the upper limit of the normal
euploid range, CAS 200 diagnosed aneuploidy in 2/4
ACIS screen showing montage of microscopically selected and operator edited Feulgen-stained nuclei and the DNA content  histogram generated on the basis of integrated optical density Figure 1
ACIS screen showing montage of microscopically selected and operator edited Feulgen-stained nuclei and the DNA content 
histogram generated on the basis of integrated optical density.BMC Clinical Pathology 2005, 5:7 http://www.biomedcentral.com/1472-6890/5/7
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DI histograms generated by the CAS 200 (the middle column) and ACIS (the right column) Figure 2
DI histograms generated by the CAS 200 (the middle column) and ACIS (the right column). The left column shows typical his-
tology of the Barrett's related lesions (H&E stained, 400×) including specialized intestinal metaplasia without dysplasia (row A), 
low-grade dysplasia (row B), high-grade dysplasia (row C), and adenocarcinoma (row D). The corresponding DI histograms 
showed progressive increases in DNA content as disease progressed. On each DI histogram, the Y axis represents the number 
of total cells included and the X axis shows changes in DNA content in arbitrary units.BMC Clinical Pathology 2005, 5:7 http://www.biomedcentral.com/1472-6890/5/7
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(50%) cases of SIM with no dysplasia, 3/7 (43%) cases of
LGD, 11/12 (92%) cases of HGD, and 7/8 (88%) cases of
EAC, whereas the ACIS diagnosed aneuploidy in all of
these tissue samples (Table 1). Using 1.29 as the upper
limit of the normal DI range, CAS 200 detected aneu-
ploidy in 1/4 (25%) cases of SIM with no dysplasia, 0/7
(0%) cases of LGD, 10/12 (83%) cases of HGD, and 6/8
(75%) cases of EAC. In contrast, the ACIS diagnosed ane-
uploidy in 3/4 (75%) cases of SIM with no dysplasia, 4/7
(57%) cases of LGD, 11/12 (92%) cases of HGD, and 8/8
(100%) cases of EAC. Together, these findings indicate
that the ACIS is more sensitive than the CAS 200 in diag-
nosing aneuploidy based on DI values of the G0/G1 peak.
Reproducibility of ACIS DI values
The DI values of G0/G1 peaks from an assortment of 30
Barrett's associated lesions were analyzed for inter- and
intra-observer variability. For inter-observer variability,
the Pearson coefficient of correlation was 0.917 (p <
0.0001, 2-tailed, n = 30), whereas, for intra-observer vari-
ability, it was 0.920 (p < 0.0001, 2-tailed, n = 30), thus
showing that ACIS gives highly reproducible DI values.
Discussion
Results have indicated that analysis of DNA ploidy may be
a better method for the detection of pre-malignant lesions
at high risk of malignant progression than histopatholog-
ical dysplasia [4,8-10,14]. In addition, DNA aneuploidy
may indicate the aggressiveness of malignant neoplasms
in a variety of organs, including the prostate, breast,
urothelial tract, cervix, ovary, lung, skin, and oral mucosa
[3,4,15-20]. Moreover, very early DNA alterations, such as
single chromosome or locus specific chromosomal abnor-
malities, may occur prior to expression of DNA
abnormalities.
DNA ploidy analysis of solid tumors can be performed on
cell suspensions using flow or image cytometry. Image
cytometry performed on histological sections allows
selective examination of the targeted epithelial cells. In
addition, flow cytometry is less sensitive than image
cytometry, and many lesions diagnosed as euploid on
flow cytometry have been found to be aneuploid on
image cytometry [6,7]. In Barrett's related esophageal
lesions, however, only flow cytometry has been used in
the diagnosis of large series of patients (14), indicating the
need for large-scale studies of image cytometry in these
lesions [8].
Diagnosis of aneuploidy by image cytometry has not been
standardized. Different laboratories use different image
Comparison of DI values as determined by the CAS 200 and  ACIS methods in various Barrett's lesions (p < 0.001, paired t  test) Figure 3
Comparison of DI values as determined by the CAS 200 and 
ACIS methods in various Barrett's lesions (p < 0.001, paired t 
test). Dots represent individual sections examined by both 
instruments.
Linear regression analysis of DI values determined on the  CAS 200 and ACIS instruments (n = 37) Figure 4
Linear regression analysis of DI values determined on the 
CAS 200 and ACIS instruments (n = 37). Note the excellent 
correlation obtained by the two systems. R = 0.89, p < 0.01 
(two tailed).BMC Clinical Pathology 2005, 5:7 http://www.biomedcentral.com/1472-6890/5/7
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cytometry systems, DNA staining techniques, section
thicknesses, and types of control cells. Among the systems
used are the CAS 100 [21] and CAS 200-Cell Analysis Sys-
tem Image Analyzers (Becton-Dickinson, San Jose, CA)
[8,14,22,23], the QPATH (LEICA, Cambridge, England)
[24], the MPV3 (Leitz, Wetzlar, Germany) equipped with
a DNA cytometry system (ACAS, Ahrens, Bargteheide,
Germany) [25], the Cyto-Savant Image Analyzer (Onco-
metrics Inc, British Columbia, Canada) [26,27]; the
SAMBA 4000 Image Analyzer (Imaging Products
International, Chantilly, VA) [28], and the Firefield ploidy
system (Firefield Imaging Ltd, Nottingham, UK) [4,16].
The performance of these instruments has not been com-
pared systematically and there is little published data
comparing them. We therefore compared the results of DI
analysis obtained by the ACIS and CAS 200 systems. We
found that DI determination obtained by these two sys-
tems were well correlated, but that the DI values obtained
with the ACIS were consistently higher than those
acquired on the CAS 200. We also found that the ACIS was
more sensitive in diagnosing aneuploidy, and that the
protocol using the ACIS took less time than the CAS 200.
Finally, the DI values obtained by the ACIS were highly
reproducible.
We were somewhat surprised that the DI values obtained
using the ACIS were consistently higher than those
obtained using the CAS 200, inasmuch as similar image
analysis systems should yield similar results. There are
several possible explanations for this difference. First, the
ChromaVision Blue Feulgen Stain Kit we used with the
ACIS is composed of a Schiff reagent, which is truly stoi-
chiometric, enabling a complete and thorough penetra-
tion of the stain and permitting uniform staining of the
DNA molecules. Second, DI values are also dependent
upon nuclear morphological features, including nuclear
area, shape and density, and the ACIS system may more
thoroughly account for these morphological features.
Third, the tissue sections used for the ACIS (7 µm) were
thicker than those used for the CAS 200 (5 µm). The latter
system uses thinner sections to decrease the incidence of
nuclear overlap, but it also yields an increased frequency
of cut nuclei. The CAS 200 addressed this issue by using a
tissue correction factor, which in essence is a right shift
applied to the DI histogram and bringing the values into
an acceptable numerical range. This correction may per-
mit the detection of small aneuploid and tetraploid peaks,
thereby preventing a 10% to 15% underestimate of aneu-
ploid cases as diploid. The software, however, may not
fully correct for nuclear truncation. In contrast, the thicker
sections used in the ACIS markedly decrease the frequency
of cut nuclei, thus avoiding the need for an artificial math-
ematical shift in the DI histograms. The ACIS uses a set of
image processing algorithms (known as Watershed Seg-
mentation) to consistently separate touching or moder-
ately overlapping nuclei. In these algorithms, nuclei that
touch or overlap are recognized through their size and
other morphometric parameters, and are separated
through the segmentation process by insertion of a single
pixel-wide boundary between them at the point of con-
tact. The analysis software provides five distinct cell sepa-
ration profiles to allow optimal separation across a range
of specimen morphologies. Each of these cell separation
profiles is designed to recognize and exclude nuclei that
exhibit excessive overlap based on signature combina-
tions of size, shape, color and morphometric filter
descriptors. In addition, the system allows the user to fur-
ther delete any overlapping nuclear images and artifacts
that may evade aneuploidy detection by ACIS. In this
fashion, sufficient numbers of nuclei can be obtained
from thicker sections without the complications of cut
cells and the requirement for tissue correction factors.
Another difference between these two systems is in their
control cells. The ACIS uses benign stromal cells, such as
endothelial cells, macrophages, fibroblasts, and large lym-
Table 1: Prevalence of aneuploidy in various Barrett's lesions on the basis of 2 different DI cut-off upper limits
DI ≥1.1 ≥1.3
CAS 200 ACIS CAS 200 ACIS
C-GI 0/3 (0%) 0/3 (0%) 0/3 (0%) 0/3 (0%)
SIM 2/4(50%) 4/4(100%) 1/4(25%) 3/4(75%)
LGD 3/7(43%) 7/7(100%) 0/7(0%) 4/7(57%)
HGD 11/12(92%) 12/12(100%) 10/12(83%) 11/12(92%)
EAC 7/8(88%) 8/8(100%) 6/8(75%) 8/8(100%)
Total 23/34(68%) 31/34(91%) 17/34(50%) 26/34(76%)
Abbreviations: C-GI, normal gastrointestinal mucosa; SIM, specialized intestinal metaplasia; LGD, low grade dysplasia; HGD, high grade dysplasia; 
EAC, esophageal adenocarcinoma.BMC Clinical Pathology 2005, 5:7 http://www.biomedcentral.com/1472-6890/5/7
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phocytes, whereas the CAS 200 uses inactive small lym-
phocytes. Inactive small lymphocytes have more
condensed nuclear chromatin structure than benign stro-
mal cells and may not be stained optimally with the
Feulgen dye. However, the lower IODs of lymphocytes
would yield higher DI values for the epithelial cells. Some
users of CAS 200 have also used external reference cells,
such as rat hepatocytes or normal urothelial cells or
human cerebellar cells. In general, selection of control
cells may not make a dramatic difference in DI determina-
tion unless the controls are actively dividing cells such as
gastrointestinal epithelial cells. It is therefore unlikely that
the selection of control cells can explain the significant
differences in the DI values generated by these two
systems.
One of the main limitations of this study is that the two
imaging systems were operated by different individuals,
and operator related differences may yield different
results. For example, differences in determining the
threshold of digitized nuclear images may yield different
values for DNA content, thereby changing the appearance
of the DNA histograms. Moreover, the exact same cells
were not analyzed by the two systems, adding to the vari-
ability in the results, although this difference was unlikely
to produce consistently lower valves for the CAS 200.
The diagnosis of an aneuploid G0/G1 peak depends on its
distinct separation from the normal diploid peak. Several
performance measures have been proposed to allow
image cytometry systems to identify aneuploidy if the DI
peak deviates more than 10% from the diploid peak [29],
but these measures are rarely reported in published stud-
ies [8,22-27]. Similarly, these studies rarely state the crite-
ria by which the DI peak is determined. Euploidy
(diploidy) may be diagnosed when cells in the G0/G1
peak have a mean DI value of less than 1.1 [22,23,26,27]
or less than 1.3 [8,24,25]. In formalin-fixed gastrointesti-
nal tissues, where the normal mucosa may have a mean
DI value in the G0/G1 peak up to 1.29, a DI cut-off value
of 1.3 seems more appropriate. In this study, we analyzed
the prevalence of aneuploidy with the two cytometers
using DI cut-off values of 1.1 and 1.30. We found that the
ACIS was more sensitive than the CAS 200 in diagnosing
aneuploidy using either cut-off value.
Aneuploidy has also been diagnosed in the presence of a
normal euploid G0/G1 peak when additional aneuploid
peaks, as evidenced by peaks of cells with DI values greater
than those of the cells in the G0/G1 peak, are identified.
However, what constitutes the aneuploid peaks is not
clear. The number of nuclei in the G2 phase that are con-
sidered abnormal (tetraploid aneuploidy) varies from
>10% [4] to >15% [8,27] to >25% [23]. Similarly,
aneuploidy has been diagnosed when there are additional
well-defined aneuploid peaks or when the number of
nuclei with DI values in the aneuploid region constitute
>1% of the total cells [4]. In this study, we did not diag-
nose aneuploidy when a normal diploid G0/G1 peak was
present. Rather, we diagnosed aneuploidy only when the
G0/G1 peak was clearly outside the diploid range. Since
ACIS is more sensitive and yields higher DI values
throughout the entire range of the DI, it will detect aneu-
ploidy more frequently using similar diagnostic criteria.
To compare the two systems, we used an assortment of tis-
sues with different histological types, including special-
ized intestinal metaplasia, various grades of dysplasia and
adenocarcinoma, so that the full spectrum of pathological
lesions may be covered. We found that the type of histol-
ogy did not affect the results, in that the ACIS yielded
higher DI values than the CAS 200 regardless of the type
of histological lesions.
Conclusion
ACIS provides a sensitive, efficient and highly reproduci-
ble method of DNA ploidy determination, and results
obtained using this system correlated well with those
obtained by the CAS 200. The ACIS system yielded DI val-
ues that were consistently higher than those obtained by
the CAS 200. Variables such as the DNA stain used, the
thickness of tissue sections, the tissue correction factor
and the capture of morphological features of the nuclei
may account for differences in results obtained with these
two image cytometers. Moreover, automated image cap-
ture, semi-automated collection of cell nuclei, easy on-
screen navigation and overall improved workflow may
contribute to the shorter time needed for ploidy determi-
nation using the ACIS. Our findings indicate the impor-
tance of standardizing DNA content and ploidy
determination methods.
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